Medicus Pharma Ltd. (MDCX) Form 424B3 — Oct 23, 2026
Medicus Pharma filed Prospectus Supplement No. 11 to register 64,911 common shares issuable upon exercise of warrants with a $4.64 exercise price, expiring November 15, 2029, under its S-1 registration statement. The attached 8-K discloses that on October 20, 2026 Nasdaq issued a delisting determination because the company missed the October 19, 2026 deadline to regain the $1.00 minimum bid price, and it was ineligible for a second 180-day period due to the $5 million stockholders' equity requirement.
Key figures
- Warrant expiration
- November 15, 2029
- Compliance period end
- October 19, 2026
- Warrant exercise price
- $4.64
- Share price oct 22 2026
- $2.62
- Warrant price oct 22 2026
- $0.21
- Warrant shares registered
- 64911
- Compliance regained window
- October 12-23, 2026 (10 consecutive business days at or above $1.00)
- Minimum bid price requirement
- $1.00
- Stockholders equity shortfall threshold
- $5 million
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.